These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401). Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912 [TBL] [Abstract][Full Text] [Related]
3. Naturally processed and presented epitopes of the islet cell autoantigen IA-2 eluted from HLA-DR4. Peakman M; Stevens EJ; Lohmann T; Narendran P; Dromey J; Alexander A; Tomlinson AJ; Trucco M; Gorga JC; Chicz RM J Clin Invest; 1999 Nov; 104(10):1449-57. PubMed ID: 10562307 [TBL] [Abstract][Full Text] [Related]
4. Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages. Tsark EC; Wang W; Teng YC; Arkfeld D; Dodge GR; Kovats S J Immunol; 2002 Dec; 169(11):6625-33. PubMed ID: 12444176 [TBL] [Abstract][Full Text] [Related]
5. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model. von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH Arthritis Rheum; 2006 Feb; 54(2):482-91. PubMed ID: 16447222 [TBL] [Abstract][Full Text] [Related]
6. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice. Andersson EC; Hansen BE; Jacobsen H; Madsen LS; Andersen CB; Engberg J; Rothbard JB; McDevitt GS; Malmström V; Holmdahl R; Svejgaard A; Fugger L Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7574-9. PubMed ID: 9636191 [TBL] [Abstract][Full Text] [Related]
7. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice. Sakurai Y; Brand DD; Tang B; Rosloniec EF; Stuart JM; Kang AH; Myers LK Arthritis Res Ther; 2006; 8(5):R150. PubMed ID: 16982003 [TBL] [Abstract][Full Text] [Related]
8. Use of soluble peptide-DR4 tetramers to detect synovial T cells specific for cartilage antigens in patients with rheumatoid arthritis. Kotzin BL; Falta MT; Crawford F; Rosloniec EF; Bill J; Marrack P; Kappler J Proc Natl Acad Sci U S A; 2000 Jan; 97(1):291-6. PubMed ID: 10618411 [TBL] [Abstract][Full Text] [Related]
9. Endogenous HLA class II epitopes that are immunogenic in vivo show distinct behavior toward HLA-DM and its natural inhibitor HLA-DO. Kremer AN; van der Meijden ED; Honders MW; Goeman JJ; Wiertz EJ; Falkenburg JH; Griffioen M Blood; 2012 Oct; 120(16):3246-55. PubMed ID: 22889757 [TBL] [Abstract][Full Text] [Related]
10. Breaking T cell tolerance against self type II collagen in HLA-DR4-transgenic mice and development of autoimmune arthritis. Batsalova T; Dzhambazov B; Merky P; Bäcklund A; Bäcklund J Arthritis Rheum; 2010 Jul; 62(7):1911-20. PubMed ID: 20309862 [TBL] [Abstract][Full Text] [Related]
11. Tracking of proinflammatory collagen-specific T cells in early and late collagen-induced arthritis in humanized mice. Svendsen P; Andersen CB; Willcox N; Coyle AJ; Holmdahl R; Kamradt T; Fugger L J Immunol; 2004 Dec; 173(11):7037-45. PubMed ID: 15557201 [TBL] [Abstract][Full Text] [Related]
12. Editing of an immunodominant epitope of glutamate decarboxylase by HLA-DM. Lich JD; Jayne JA; Zhou D; Elliott JF; Blum JS J Immunol; 2003 Jul; 171(2):853-9. PubMed ID: 12847254 [TBL] [Abstract][Full Text] [Related]
13. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen. Rosloniec EF; Whittington KB; Zaller DM; Kang AH J Immunol; 2002 Jan; 168(1):253-9. PubMed ID: 11751969 [TBL] [Abstract][Full Text] [Related]
14. HLA-DR4 molecules in neuroendocrine epithelial cells associate to a heterogeneous repertoire of cytoplasmic and surface self peptides. Muntasell A; Carrascal M; Serradell L; Veelen Pv Pv; Verreck F; Koning F; Raposo G; Abián J; Jaraquemada D J Immunol; 2002 Nov; 169(9):5052-60. PubMed ID: 12391221 [TBL] [Abstract][Full Text] [Related]
15. [Relationship between HLA-DR4/1 subtypes and T cell responses to type II collagen or anti-C II 263-272 antibodies]. Li X; Li R; Ning XR; Li ZG Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 37(6):582-4. PubMed ID: 16378106 [TBL] [Abstract][Full Text] [Related]
16. T cell responses to a human cartilage autoantigen in the context of rheumatoid arthritis-associated and nonassociated HLA-DR4 alleles. Cope AP; Patel SD; Hall F; Congia M; Hubers HA; Verheijden GF; Boots AM; Menon R; Trucco M; Rijnders AW; Sønderstrup G Arthritis Rheum; 1999 Jul; 42(7):1497-507. PubMed ID: 10403279 [TBL] [Abstract][Full Text] [Related]
17. [Proliferation of type II collagen specific T cell response and antibody formation in rheumatoid arthritis and their relations to HLA-DR4]. Zhou Q; Li X; Li R; Zheng WY; Li ZG Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):370-3. PubMed ID: 15854524 [TBL] [Abstract][Full Text] [Related]
18. Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. Fridkis-Hareli M; Rosloniec EF; Fugger L; Strominger JL Hum Immunol; 2000 Jul; 61(7):640-50. PubMed ID: 10880734 [TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8. Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392 [TBL] [Abstract][Full Text] [Related]
20. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Bäcklund J; Carlsen S; Höger T; Holm B; Fugger L; Kihlberg J; Burkhardt H; Holmdahl R Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9960-5. PubMed ID: 12089323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]